ESC Premium Access

Best abstracts from ESC Congress 2021

Event: ESC Asia with APSC & AFC 2021
Topic: European Society of Cardiology
Session type: Special Session
Date: 2 December 2021
Time: 08:00 - 20:00

Session

12 presentations in this session

Impact of the COVID-19 pandemic on cardiology services at a tertiary cardiac centre in a low- & middle-income country in Asia.

Speaker: Doctor F. Cader (Dhaka, BD)
Thumbnail

Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis.

Speaker: Doctor W. Sun (Shatin, HK)
Thumbnail

Socio-economic variations in the clinical presentation, etiology and outcome of infective endocarditis in the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry: a prospective cohort study.

Speaker: Doctor S. Sengupta (Nagpur, IN)
Thumbnail

Impact of supervised physical training on vasovagal syncope; a randomized controlled trial.

Speaker: Assistant Professor M. Tajdini (Tehran, IR)
Thumbnail

Psychological assessment of depression and anxiety in patients with implantable cardioverter-defibrillator: DEFibrillator-related distress and depression survey in Chiba 2.

Speaker: Associate Professor Y. Kondo (Chiba, JP)
Thumbnail

Longitudinal strain measurement by 3D modelling from cine CMR: feasibility and comparison to 2D speckle tracking echocardiography.

Speaker: Miss D. Zhao (Auckland, NZ)
Thumbnail

Intracoronary pharmacological therapy versus aspiration thrombectomy in patients presenting with ST-segment elevation myocardial infarction (IPAT-STEMI): a systematic review and meta-analysis.

Speaker: Doctor R. Kaddoura (Doha, QA)
Thumbnail

Endothelial-T cell crosstalk contributes to vascular injury in fatty liver disease.

Speaker: Assistant Professor C. Cheung (Singapore, SG)
Thumbnail

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation: A nationwide cohort study.

Speaker: Doctor T. Chao (Taipei, TW)
Thumbnail

Low-dose rivaroxaban associated with lower incidence of all-cause mortality and bleeding complications in older patients with non-valvular atrial fibrillation.

Speaker: Doctor W. Chiou (Taitung, TW)
Thumbnail

12 speakers from this session

Doctor Fathima Aaysha Cader

Ibrahim Cardiac Hospital & Research Institute, Dhaka (Bangladesh)
1 presentation
1 follower

Doctor Wen Sun

Prince of Wales University Hospital, Shatin (Hong Kong)
1 presentation
0 follower

Doctor Shantanu Sengupta

Sengupta Hospital and Research Institute, Nagpur (India)
3 presentations
0 follower

Assistant Professor Masih Tajdini

Tehran Heart Center, Tehran (Iran (Islamic Republic of))
1 presentation
0 follower

Associate Professor Yusuke Kondo

Chiba University Graduate School of Medicine, Department of Cardiovascular Science and Medicine, Chiba (Japan)
1 presentation
0 follower

Miss Debbie Zhao

The University of Auckland, Auckland (New Zealand)
1 presentation
0 follower

Doctor Rasha Kaddoura

Hamad Medical Corporation Heart Hospital, Doha (Qatar)
1 presentation
0 follower

Assistant Professor Christine Cheung

Nanyang Technological University, Singapore (Singapore)
1 presentation
0 follower

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)
3 presentations
0 follower

Doctor Wei-Ru Chiou

Mackay Memorial Hospital Taitung, Taitung (Taiwan)
1 presentation
0 follower

Doctor Ply Chichareon

Prince of Songkla University, Hat Yai (Thailand)
1 presentation
0 follower

Doctor Yosef Manla

Cleveland Clinic, Abu Dhabi (United Arab Emirates)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk